CB1 Receptors Were Concentrated in the Part of the Eye That Controls Fluid Pressure | Research

The takeaway

CB1 cannabinoid receptor mRNA was found at high levels in the rat ciliary body, the eye structure that produces fluid controlling eye pressure, providing a molecular explanation for how cannabinoids lower eye pressure in glaucoma.

Read this if you want to understand the biological mechanism behind cannabis lowering eye pressure.

CB1 receptor mRNA was 12 times higher in ciliary body than retina

What the researchers found

Researchers used molecular techniques to measure cannabinoid receptor levels across different structures of the rat eye. CB1 receptor mRNA was found at significantly higher levels in the ciliary body (the structure that produces aqueous humor, the fluid that determines eye pressure) compared to the iris, retina, and choroid.

The CB2 receptor, associated primarily with immune function, was undetectable in any eye structure.

This distribution pattern provided the first molecular evidence for a specific mechanism by which cannabinoids could lower eye pressure: by acting on CB1 receptors in the ciliary body, cannabinoids could potentially reduce the production of aqueous humor, directly lowering intraocular pressure.

Why it matters

For decades, researchers knew cannabis lowered eye pressure but did not understand the mechanism. This study identified where the receptors are concentrated, pointing to a local mechanism in the ciliary body rather than a purely systemic effect, potentially reviving interest in topical cannabinoid eye drops.

The numbers in context

CB1 mRNA in ciliary body: 0.84% of reference gene. Iris: 0.34%. Retina: 0.07%. Choroid: 0.06%. CB2: undetectable in all structures.

How the study worked

RT-PCR measurement of CB1 and CB2 receptor mRNA in four rat eye structures: ciliary body, iris, retina, and choroid. Levels were normalized to the reference gene beta-2 microglobulin.

What this study cannot tell us

Rat eye anatomy may differ from human. mRNA levels do not necessarily correspond to functional protein levels. The study did not demonstrate that activating these receptors actually reduced aqueous humor production.

How to read the evidence

An animal molecular biology study identifying receptor distribution. Provides mechanistic insight but does not demonstrate functional effects.

When this study was published

Published in 1998. Cannabinoid-based glaucoma treatments have not become mainstream, as other drug classes have proven more practical.

The bigger picture

This finding challenged earlier conclusions that cannabinoids lower eye pressure only through systemic mechanisms. The high concentration of CB1 receptors in the ciliary body suggested a local mechanism could work, if the right delivery system could get cannabinoids to these receptors.

Questions still open

Do human eyes show the same CB1 distribution? Can topical cannabinoids activate ciliary body CB1 receptors effectively? Would CB1-selective agonists make better glaucoma drugs than THC?

Common questions

Why do cannabinoids lower eye pressure?

This study found CB1 receptors are concentrated in the ciliary body, which produces the fluid that determines eye pressure. Cannabinoids may lower pressure by acting on these receptors to reduce fluid production.

Could this lead to cannabis eye drops?

Potentially. The high receptor concentration in the ciliary body suggests a local mechanism could work, but practical delivery challenges remain.

Read the original research

Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana.

Brain research. Molecular brain research, 58(1-2), 240-5

View on PubMed

Citation

Porcella, A; Casellas, P; Gessa, G L; Pani, L. (1998). Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana.. Brain research. Molecular brain research, 58(1-2), 240-5.